{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:02:16Z","timestamp":1784307736062,"version":"3.55.0"},"reference-count":70,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:00:00Z","timestamp":1642550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006747","name":"Fondazione Cariverona","doi-asserted-by":"publisher","award":["B34I19002690003"],"award-info":[{"award-number":["B34I19002690003"]}],"id":[{"id":"10.13039\/501100006747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","award":["754345"],"award-info":[{"award-number":["754345"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Amyotrophic lateral sclerosis (ALS) is a fatal adult-onset neurodegenerative disorder. There is no cure and current treatments fail to slow the progression of the disease. Epigenetic modulation in the acetylation state of NF-kB RelA and the histone 3 (H3) protein, involved in the development of neurodegeneration, is a drugable target for the class-I histone deacetylases (HDAC) inhibitors, entinostat or valproate, and the AMP-activated kinase (AMPK)-sirtuin 1 pathway activator, resveratrol. In this study, we demonstrated that the combination of valproate and resveratrol can restore the normal acetylation state of RelA in the SOD1(G93A) murine model of ALS, in order to obtain the neuroprotective form of NF-kB. We also investigated the sexually dimorphic development of the disease, as well as the sex-sensibility to the treatment administered. We showed that the combined drugs, which rescued AMPK activation, RelA and the histone 3 acetylation state, reduced the motor deficit and the disease pathology associated with motor neuron loss and microglial reactivity, Brain-Derived Neurotrophic Factor (BDNF) and B-cell lymphoma-extra large (Bcl-xL) level decline. Specifically, vehicle-administered males showed earlier onset and slower progression of the disease when compared to females. The treatment, administered at 50 days of life, postponed the time of onset in the male by 22 days, but not in a significant way in females. Nevertheless, in females, the drugs significantly reduced symptom severity of the later phase of the disease and prolonged the mice\u2019s survival. Only minor beneficial effects were produced in the latter stage in males. Overall, this study shows a beneficial and sexually dimorphic response to valproate and resveratrol treatment in ALS mice.<\/jats:p>","DOI":"10.3390\/ijms23031047","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T08:20:57Z","timestamp":1642580457000},"page":"1047","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Beneficial and Sexually Dimorphic Response to Combined HDAC Inhibitor Valproate and AMPK\/SIRT1 Pathway Activator Resveratrol in the Treatment of ALS Mice"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3374-0614","authenticated-orcid":false,"given":"Oluwamolakun","family":"Bankole","sequence":"first","affiliation":[{"name":"Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7678-6359","authenticated-orcid":false,"given":"Ilaria","family":"Scambi","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0365-5144","authenticated-orcid":false,"given":"Edoardo","family":"Parrella","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, Division of Pharmacology, University of Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8060-6528","authenticated-orcid":false,"given":"Matilde","family":"Muccilli","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Bonafede","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermanna","family":"Turano","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Pizzi","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, Division of Pharmacology, University of Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Mariotti","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"17085","DOI":"10.1038\/nrdp.2017.85","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13024-020-00406-3","article-title":"Neurofilaments in motor neuron disorders: Towards promising diagnostic and prognostic biomarkers","volume":"15","author":"Zucchi","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"ref_3","first-page":"49","article-title":"The genetics of amyotrophic lateral sclerosis: Current insights","volume":"6","author":"Alsultan","year":"2016","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/endrev\/bnz005","article-title":"The Role of Sex and Sex Hormones in Neurodegenerative Diseases","volume":"41","author":"Vegeto","year":"2020","journal-title":"Endocr. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3233\/JND-140068","article-title":"Characterization of the Contribution of Genetic Background and Gender to Disease Progression in the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis: A Meta-Analysis","volume":"2","author":"Pfohl","year":"2015","journal-title":"J. Neuromuscul. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40478-015-0271-6","article-title":"Early and gender-specific differences in spinal cord mitochondrial function and oxidative stress markers in a mouse model of ALS","volume":"4","author":"Cacabelos","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1080\/21678421.2018.1511732","article-title":"Epidemiology of amyotrophic lateral sclerosis in Friuli-Venezia Giulia, North-Eastern Italy, 2002-2014: A retrospective population-based study","volume":"20","author":"Palese","year":"2019","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/jnnp-2018-318974","article-title":"Epidemiology of ALS in Korea using nationwide big data","volume":"90","author":"Jun","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3109\/17482968.2012.706303","article-title":"Amyotrophic lateral sclerosis: A hormonal condition?","volume":"13","author":"Blasco","year":"2012","journal-title":"Amyotroph. Lateral Scler."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fncel.2017.00080","article-title":"ALS Pathogenesis and Therapeutic Approaches: The Role of Mesenchymal Stem Cells and Extracellular Vesicles","volume":"11","author":"Bonafede","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/978-3-319-89689-2_10","article-title":"Senataxin, A Novel Helicase at the Interface of RNA Transcriptome Regulation and Neurobiology: From Normal Function to Pathological Roles in Motor Neuron Disease and Cerebellar Degeneration","volume":"20","author":"Bennett","year":"2018","journal-title":"Adv. Neurobiol."},{"key":"ref_12","first-page":"302","article-title":"Epigenetic marks: Regulators of livestock phenotypes and conceivable sources of missing variation in livestock improvement programs","volume":"6","author":"Zhao","year":"2015","journal-title":"Front. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/nrneurol.2015.57","article-title":"Amyotrophic lateral sclerosis: Mechanisms and therapeutics in the epigenomic era","volume":"11","author":"Sakowski","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00401-016-1587-4","article-title":"ALS and FTD: An epigenetic perspective","volume":"132","author":"Belzil","year":"2016","journal-title":"Acta Neuropathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1038\/sj.onc.1210599","article-title":"HATs and HDACs: From structure, function and regulation to novel strategies for therapy and prevention","volume":"26","author":"Yang","year":"2007","journal-title":"Oncogene"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3389\/fimmu.2019.01043","article-title":"Cellular Specificity of NF-kappaB Function in the Nervous System","volume":"10","author":"Dresselhaus","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fnagi.2020.00068","article-title":"Nuclear Factor-kappaB Dysregulation and alpha-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson\u2019s Disease","volume":"12","author":"Bellucci","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1517\/14728222.2014.989834","article-title":"Significance of NF-kappaB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer\u2019s disease and multiple sclerosis","volume":"19","author":"Srinivasan","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3389\/fneur.2015.00098","article-title":"NF-kappaB in Innate Neuroprotection and Age-Related Neurodegenerative Diseases","volume":"6","author":"Lanzillotta","year":"2015","journal-title":"Front. Neurol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1600-065X.2012.01096.x","article-title":"NF-kappaB: Where did it come from and why?","volume":"246","author":"Gilmore","year":"2012","journal-title":"Immunol. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1038\/cddis.2010.76","article-title":"The acetylation of RelA in Lys310 dictates the NF-kappaB-dependent response in post-ischemic injury","volume":"1","author":"Lanzillotta","year":"2010","journal-title":"Cell Death Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/1073858412444007","article-title":"NF-kappaB signaling pathways: Role in nervous system physiology and pathology","volume":"19","author":"Soler","year":"2013","journal-title":"Neuroscientist"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"K\u00e4llstig, E., McCabe, B.D., and Schneider, B.L. (2021). The Links between ALS and NF-\u03baB. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22083875"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.celrep.2015.06.019","article-title":"The Regulatory Machinery of Neurodegeneration in In Vitro Models of Amyotrophic Lateral Sclerosis","volume":"12","author":"Ikiz","year":"2015","journal-title":"Cell Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jneuroim.2014.03.005","article-title":"Endoplasmic reticulum stress is accompanied by activation of NF-kappaB in amyotrophic lateral sclerosis","volume":"270","author":"Prell","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mcn.2018.05.004","article-title":"Astrocyte elevated gene-1 is a novel regulator of astrogliosis and excitatory amino acid transporter-2 via interplaying with nuclear factor-kappaB signaling in astrocytes from amyotrophic lateral sclerosis mouse model with hSOD1(G93A) mutation","volume":"90","author":"Yin","year":"2018","journal-title":"Mol. Cell Neurosci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.neuron.2014.01.013","article-title":"Microglia induce motor neuron death via the classical NF-kappaB pathway in amyotrophic lateral sclerosis","volume":"81","author":"Frakes","year":"2014","journal-title":"Neuron"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1084\/jem.20111313","article-title":"Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor kappaB-mediated pathogenic pathways","volume":"208","author":"Swarup","year":"2011","journal-title":"J. Exp. Med."},{"key":"ref_29","first-page":"1129","article-title":"Gene expression profile of spinal ventral horn in ALS","volume":"59","author":"Yamamoto","year":"2007","journal-title":"Brain Nerve"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/ana.20379","article-title":"Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis","volume":"57","author":"Jiang","year":"2005","journal-title":"Ann. Neurol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"12875","DOI":"10.1038\/s41598-018-30659-4","article-title":"Acetylation state of RelA modulated by epigenetic drugs prolongs survival and induces a neuroprotective effect on ALS murine model","volume":"8","author":"Schiaffino","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_32","first-page":"243","article-title":"Histone deacetylases and their role in motor neuron degeneration","volume":"7","author":"Tovar","year":"2013","journal-title":"Front. Cell Neurosci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","article-title":"Basic pharmacology of valproate: A review after 35 years of clinical use for the treatment of epilepsy","volume":"16","author":"Loscher","year":"2002","journal-title":"CNS Drugs"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"645518","DOI":"10.3389\/fcell.2021.645518","article-title":"Sodium Valproate-Induced Chromatin Remodeling","volume":"9","author":"Mello","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.neuroscience.2008.06.040","article-title":"Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model","volume":"155","author":"Feng","year":"2008","journal-title":"Neuroscience"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s13311-013-0253-y","article-title":"Resveratrol improves motoneuron function and extends survival in SOD1(G93A) ALS mice","volume":"11","author":"Mancuso","year":"2014","journal-title":"Neurotherapeutics"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.nbd.2012.08.018","article-title":"Targeted acetylation of NF-kappaB\/RelA and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window","volume":"49","author":"Lanzillotta","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"E751","DOI":"10.1152\/ajpendo.00745.2009","article-title":"AMPK and SIRT1: A long-standing partnership?","volume":"298","author":"Ruderman","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1080\/13543784.2017.1353077","article-title":"Entinostat for the treatment of breast cancer","volume":"26","author":"Trapani","year":"2017","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_40","first-page":"316","article-title":"Post-insult valproic acid-regulated microRNAs: Potential targets for cerebral ischemia","volume":"4","author":"Hunsberger","year":"2012","journal-title":"Am. J. Transl. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1161\/STROKEAHA.112.652545","article-title":"Chronic valproate treatment enhances postischemic angiogenesis and promotes functional recovery in a rat model of ischemic stroke","volume":"43","author":"Wang","year":"2012","journal-title":"Stroke"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1039\/C7FO01300K","article-title":"A comprehensive review of the health perspectives of resveratrol","volume":"8","author":"Rauf","year":"2017","journal-title":"Food Funct."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Faggi, L., Pignataro, G., Parrella, E., Porrini, V., Vinciguerra, A., Cepparulo, P., Cuomo, O., Lanzillotta, A., Mota, M., and Benarese, M. (2018). Synergistic Association of Valproate and Resveratrol Reduces Brain Injury in Ischemic Stroke. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19010172"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.nbd.2015.05.002","article-title":"N-acetyl-L-tryptophan delays disease onset and extends survival in an amyotrophic lateral sclerosis transgenic mouse model","volume":"80","author":"Li","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1047-9651(18)30070-6","article-title":"The role of neurotrophic factors in disorders of peripheral nerves and motor neurons","volume":"12","author":"Yuen","year":"2001","journal-title":"Phys. Med. Rehabil. Clin. N. Am."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000447559","article-title":"Brain-Derived Neurotrophic Factor Facilitates Functional Recovery from ALS-Cerebral Spinal Fluid-Induced Neurodegenerative Changes in the NSC-34 Motor Neuron Cell Line","volume":"17","author":"Shruthi","year":"2017","journal-title":"Neurodegener. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/ana.410370413","article-title":"Effects of brain-derived neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease","volume":"37","author":"Ikeda","year":"1995","journal-title":"Ann. Neurol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1750-3639.2010.00431.x","article-title":"Brain-derived neurotrophic factor enhances Bcl-xL expression through protein kinase casein kinase 2-activated and nuclear factor kappa B-mediated pathway in rat hippocampus","volume":"21","author":"Chao","year":"2011","journal-title":"Brain Pathol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.tox.2013.04.004","article-title":"Motor neuron dysfunction in a mouse model of ALS: Gender-dependent effect of P2X7 antagonism","volume":"311","author":"Cervetto","year":"2013","journal-title":"Toxicology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1538\/expanim.14-0077","article-title":"Comparative study of behavioural tests in the SOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"64","author":"Olivan","year":"2015","journal-title":"Exp. Anim."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.brainres.2011.02.060","article-title":"Early motor and electrophysiological changes in transgenic mouse model of amyotrophic lateral sclerosis and gender differences on clinical outcome","volume":"1394","author":"Alves","year":"2011","journal-title":"Brain Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jns.2007.10.024","article-title":"Effects of estrogen on lifespan and motor functions in female hSOD1 G93A transgenic mice","volume":"268","author":"Choi","year":"2008","journal-title":"J. Neurol. Sci"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1212\/WNL.0000000000004390","article-title":"A case-control study of hormonal exposures as etiologic factors for ALS in women: Euro-MOTOR","volume":"89","author":"Rooney","year":"2017","journal-title":"Neurology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neulet.2017.05.017","article-title":"Expression of aromatase and estrogen receptors in lumbar motoneurons of mice","volume":"653","author":"Ji","year":"2017","journal-title":"Neurosci. Lett."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/10408444.2020.1762538","article-title":"The estrogenic activity of resveratrol: A comprehensive review of in vitro and in vivo evidence and the potential for endocrine disruption","volume":"50","author":"Qasem","year":"2020","journal-title":"Crit. Rev. Toxicol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Hajializadeh, Z., and Khaksari, M. (2021). The protective effects of 17-beta estradiol and SIRT1 against cardiac hypertrophy: A review. Heart Fail. Rev.","DOI":"10.1007\/s10741-021-10171-0"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/carcin\/bgp308","article-title":"Inhibition of SIRT1 deacetylase suppresses estrogen receptor signaling","volume":"31","author":"Yao","year":"2010","journal-title":"Carcinogenesis"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/cns.12686","article-title":"SIRT1-dependent AMPK pathway in the protection of estrogen against ischemic brain injury","volume":"23","author":"Guo","year":"2017","journal-title":"CNS Neurosci. Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.biopha.2017.10.137","article-title":"Magnesium valproate ameliorates type 1 diabetes and cardiomyopathy in diabetic rats through estrogen receptors","volume":"97","author":"Rabadiya","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mce.2009.09.011","article-title":"Valproic acid restores ER alpha and antiestrogen sensitivity to ER alpha-negative breast cancer cells","volume":"314","author":"Fortunati","year":"2010","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1158\/1535-7163.MCT-07-0197","article-title":"The relevance of estrogen receptor-beta expression to the antiproliferative effects observed with histone deacetylase inhibitors and phytoestrogens in prostate cancer treatment","volume":"6","author":"Stettner","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1111\/j.1460-9568.2004.03765.x","article-title":"Benefit of valproic acid in suppressing disease progression of ALS model mice","volume":"20","author":"Sugai","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/mus.21260","article-title":"Long-term dietary administration of valproic acid does not affect, while retinoic acid decreases, the lifespan of G93A mice, a model for amyotrophic lateral sclerosis","volume":"39","author":"Crochemore","year":"2009","journal-title":"Muscle Nerve"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1523\/JNEUROSCI.1139-07.2007","article-title":"Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model","volume":"27","author":"Rouaux","year":"2007","journal-title":"J. Neurosci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.21620","article-title":"Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis","volume":"66","author":"Piepers","year":"2009","journal-title":"Ann. Neurol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1089\/jmf.2009.0243","article-title":"A single-dose resveratrol treatment in a mouse model of amyotrophic lateral sclerosis","volume":"13","author":"Markert","year":"2010","journal-title":"J. Med. Food"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.brainres.2012.09.022","article-title":"Resveratrol upregulated heat shock proteins and extended the survival of G93A-SOD1 mice","volume":"1483","author":"Han","year":"2012","journal-title":"Brain Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"100055","DOI":"10.1016\/j.mtbio.2020.100055","article-title":"Advances in nanotechnology-based strategies for the treatments of amyotrophic lateral sclerosis","volume":"6","author":"Wang","year":"2020","journal-title":"Mater. Today Bio"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"886","DOI":"10.4103\/1673-5374.208546","article-title":"Dual and multi-drug delivery nanoparticles towards neuronal survival and synaptic repair","volume":"12","author":"Angelova","year":"2017","journal-title":"Neural Regen. Res."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Henriques, A., Pitzer, C., and Schneider, A. (2010). Characterization of a novel SOD-1(G93A) transgenic mouse line with very decelerated disease development. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0015445"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/3\/1047\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:03:52Z","timestamp":1760133832000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/3\/1047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,19]]},"references-count":70,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["ijms23031047"],"URL":"https:\/\/doi.org\/10.3390\/ijms23031047","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,19]]}}}